RxDoctor Payments Data

Danny Perlaza, NP

Adult Health · Mineola, NYNPI 1669115754

Payments from drug & device makers

$464in general payments, 2019–2025

Across 17 payments — averaging $27.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$117
  • Bristol Myers Squibb$59
  • Merck$52
  • Daiichi Sankyo Inc.$41
  • Astellas Pharma US Inc$31
  • Beone Medicines USA, Inc.$30
  • plus $133 from 7 others

What the payments were for

  • Food & beverage$464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 50th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$3,418
Medicare patients
47
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lenalidomide41$618,110
IdhifaEnasidenib Mesylate11$339,115
RevlimidLenalidomide16$288,937
TagrissoOsimertinib Mesylate12$191,634
VenclextaVenetoclax26$146,943
EliquisApixaban16$14,163
XareltoRivaroxaban12$11,803
Cefpodoxime Proxetil32$5,605
Fluconazole51$3,451
Acyclovir89$1,555
Hydroxyurea21$445
Allopurinol34$405
Ondansetron OdtOndansetron15$367
Oxycodone Hcl11$325
Levofloxacin14$211

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbIdhifa, Revlimid$59$628,05327 claims
AstraZenecaTagrisso$117$191,63412 claims
PfizerEliquis$13$14,16316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,828 adult health providers in New York.

Other adult health in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →